SAR407899

DRUG2 trials

Sponsors

Sanofi

Conditions

Erectile DysfunctionMicrovascular Coronary Artery Disease

Phase 2

SAR407899 Single-dose in Treatment of Mild to Moderate Erectile Dysfunction

CompletedNCT00914277

SanofiErectile Dysfunction

Start: 2009-05-31End: 2009-10-31Updated: 2011-05-02

A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI

TerminatedNCT03236311

SanofiMicrovascular Coronary Artery Disease

Start: 2017-10-12End: 2018-07-23Updated: 2022-03-24